SUMMARY Erythrocyte transketolase activity and the effect of adding thiamine pyrophosphate (% thiamine pyrophosphate effect) were measured in 111 subjects suspected to suffer from Leigh's disease (subacute necrotising encephalomyelopathy). From clinical evidence these subjects were divided into five groups: (1) necropsy-proved cases of subacute necrotising encephalomyelopathy, (2) cases positive for urinary thiamine pyrophosphate: adenosine triphosphate phosphotransferase inhibitor, (3) clinically likely cases of subacute necrotising encephalomyelopathy (patients still alive, or on whom no necropsy was performed), (4) cases diagnosed as diseases other than subacute necrotising encephalomyelopathy (control group), (5) cases for which no diagnosis had been made.
The symptoms and clinical and pathological findings in subacute necrotising encephalomyelopathy (SNE) or Leigh's disease were reviewed by Monpetit et al.1 and Pincus.2 The recessive mode of inheritance and the various biochemical abnormalities that have been detected suggest that the condition is the result of an inborn error of metabolism. 3 Although it generally presents before age 2 years in children who had previously been healthy, SNE can first manifest itself in adolescence or early adulthood. Clinically it is difficult to diagnose, but psychomotor retardation, the presence of cranial nerve lesions and respiratory disorders in the hypotonic child, with exacerbation and remission of the symptoms and signs may suggest the diagnosis. The difficulty in clinical diagnosis leads to uncertainty in evaluating the results of any biochemical investigations except in cases in which the diagnosis has been confirmed at necropsy, or in cases where a sibling has died with SNE proved at necropsy. However, the discovery by Cooper et Urine, minimum volume 5 ml, was dried on filter paper (Whatman 3 MM, 10 x 8 cm) as described by Cooper5 and despatched to Yale University for determination of TPP:ATP phosphotransferase inhibition by the method previously described.5 Inhibition in excess of 40 % was regarded as a positive result for the inhibitor substance.
Results
The reproducibility of the transketolase assay was determined by assaying one erythrocyte sample 10 times in the presence and absence of TPP. This The results of erythrocyte transketolase determinations are shown for all groups of subjects in Fig. 1 . Each group was compared with the control group (group 4) and there were no significant differences.
Transketolase activities after adding the TPP are presented in Fig. 2 . All groups showed increased activity and the relationships were the same as before the TPP was added. Similarly, no significant differences in the % TPP effect were observed between the groups (Fig. 3) . There was no correlation between age or sex and erythrocyte transketolase activity.
For 10 subjects blood and urine samples were 
reported that a high TPP effect does not always correlate with clinical findings19-2' and this, together with the large variation usually found in TPP effect determinations (coejmcient of variation from the mean 50-85 %), limits the clinical significance of this parameter. The values of the TPP effect quoted for our control group agree with results reported for healthy individuals.
Apart from a role in determining thiamine deficiency the activity of erythrocyte transketolase has been investigated in a number of disease states-such as alcoholism, cancer, uraemia, neurosis, diabetes mellitus, anaemia, polyneuritis, and malnourishment secondary to vascular disease of the brain. In these conditions, enzyme levels have been shown to be significantly altered only in alcoholics, neurosis, and pernicious anaemia. In alcoholics, low enzyme levels were thought to reflect poor thiamine status as alcohol has been shown to block intestinal absorption of thiamine. Patients with neurosis were concluded to be thiamine-deficient due to poor food intake. 22 Patients with pernicious anaemia showed significantly increased tranketolase activity and this was believed to be due to a larger population of young blood cells. 23 For the few cases of Leigh's disease, in which transketolase activity has been determined, the results so far have been equivocal. In one study'0 no change in activity was observed; in another'5 significantly reduced enzyme levels accompanied by a high TPP effect were observed.
In addition to erythrocyte transketolase, there is also evidence, in SNE, to implicate deficiencies in other enzymes which require thiamine pyrophosphate as cofactor-for example pyruvate decarboxylasell 24 10 necropsy-proved cases of SNE. The reason for this discrepancy is not known, but it may result from delays in assaying the urine.
At present it seems that there is no single laboratory procedure which will diagnose Leigh's disease before death and it is possible that the disease may be the result of more than one metabolic abnormality.
Current results suggest that involvement of thiamine pyrophosphate in Leigh's disease will be in a role other than that of coenzyme in erythrocyte transketolase or as precursor of thiamine triphosphate. Evidence has suggested an additional neural function of thiamine27-28 and studies have been reported on a possible function of thiamine in neuromuscular transmission.29 It remains to be seen whether or not this approach will be more fruitful in elucidating the role of thiamine in the pathogenesis of Leigh's disease. 
